Trade

with

Cooper Companies
(NYSE: COO)
AdChoices
156.21
-0.31
-0.20%
After Hours :
-
-
-

Open

157.02

Previous Close

156.52

Volume (Avg)

81.65k (540.12k)

Day's Range

155.31-157.02

52Wk Range

116.95-164.85

Market Cap.

7.56B

Dividend Rate (Yield )

0.06 (0.04%)

Beta

0.25

Shares Outstanding

48.28M

P/E Ratio (EPS)

25.97 (6.03)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Instruments & Supplies
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 1.59B

    • Net Income

    • 296.15M

    • Market Cap.

    • 7.56B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 17.84

    • PEG (Price/Earnings Growth) Ratio

    • 1.46

    • Beta

    • 0.25

    • Forward P/E

    • 18.76

    • Price/Sales

    • 4.63

    • Price/Book Value

    • 2.84

    • Price/Cash flow

    • 16.98

      • EBITDA

      • 446.79M

      • Return on Capital %

      • 9.30

      • Return on Equity %

      • 11.69

      • Return on Assets %

      • 9.30

      • Book Value/Share

      • 55.03

      • Shares Outstanding

      • 48.28M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.03 (7/22/2014)

      • Dividend Declaration Date

      • 7/10/2014

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 178.00

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • 7.38

        • Cashflow Estimate

        • 10.09

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 5.00

          • 10.42

          • Net Income

            YTD/YTD (last year)

          • 19.30

          • -15.59

          • Net Income

            Q/Q (last year)

          • -1.00

          • -8.93

          • Sales (Revenue)

            5-Year Annual Average

          • 8.35

          • 12.51

          • Net Income

            5-Year Annual Average

          • 35.20

          • 4.16

          • Dividends

            5-Year Annual Average

          • 0.00

          • 0.97

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 64.75

            • 52.83

            • Pre-Tax Margin

            • 19.42

            • 15.96

            • Net Profit Margin

            • 17.84

            • 12.40

            • Average Gross Margin

              5-Year Annual Average

            • 60.50

            • 52.66

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 14.90

            • 18.40

            • Average Net Profit Margin

              5-Year Annual Average

            • 13.60

            • 93.46B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.11

              • 0.62

              • Current Ratio

              • 3.01

              • 1.97

              • Quick Ratio

              • 1.46

              • 1.16

              • Interest Coverage

              • 49.81

              • 10.47

              • Leverage Ratio

              • 1.27

              • 2.38

              • Book Value/Share

              • 55.03

              • 12.11

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 25.97

                • 35.34

                • P/E Ratio 5-Year High

                • 27.33

                • 279.76

                • P/E Ratio 5-Year Low

                • 4.57

                • 148.87

                • Price/Sales Ratio

                • 4.63

                • 3.28

                • Price/Book Value

                • 2.84

                • 4.08

                • Price/Cash Flow Ratio

                • 16.98

                • 16.98

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 11.69

                    (9.70)

                  • 17.93

                    (21.42)

                  • Return on Assets %

                    (5-Year Average)

                  • 9.30

                    (6.80)

                  • 7.35

                    (9.50)

                  • Return on Capital %

                    (5-Year Average)

                  • 10.68

                    (8.50)

                  • 10.24

                    (13.59)

                  • Income/Employee

                  • 37.06k

                  • 25.65k

                  • Inventory Turnover

                  • 1.69

                  • 2.66

                  • Asset Turnover

                  • 0.52

                  • 0.59

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  305.94M
                  Operating Margin
                  19.27
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  16.98
                  Ownership

                  Institutional Ownership

                  -

                  Top 10 Institutions

                  47.69%

                  Mutual Fund Ownership

                  67.14%

                  Float

                  83.95%

                  5% / Insider Ownership

                  1.01%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • T. Rowe Price Mid Cap Growth Fund

                  •  

                    1,875,000

                  • 0.00

                  • 3.91

                  • Vanguard Small Cap Index

                  •  

                    832,740

                  • -0.34

                  • 1.72

                  • Vanguard Total Stock Mkt Idx

                  •  

                    780,497

                  • 0.47

                  • 1.62

                  • T. Rowe Price Health Sciences Fund

                  •  

                    740,740

                  • -0.30

                  • 1.55

                  • Munder Mid-Cap Core Growth Fund

                  •  

                    691,700

                  • -2.00

                  • 1.44

                  • Vanguard Explorer Fund

                  •  

                    671,038

                  • 25.39

                  • 1.40

                  • Fidelity® Mid-Cap Stock Fund

                  •  

                    670,965

                  • 0.00

                  • 1.39

                  • iShares Core S&P Mid-Cap (AU)

                  •  

                    659,752

                  • -0.36

                  • 1.33

                  • Fidelity Advisor® New Insights Fund

                  •  

                    617,351

                  • 0.00

                  • 1.28

                  • Vanguard Small Cap Growth Index Fund

                  •  

                    562,811

                  • -2.31

                  • 1.17

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Fidelity Management and Research Company

                  •  

                    6,947,769

                  • -0.76%

                  • 14.49

                  • T. Rowe Price Associates, Inc.

                  •  

                    4,447,122

                  • -2.71%

                  • 9.28

                  • Vanguard Group, Inc.

                  •  

                    2,932,717

                  • -0.79%

                  • 6.12

                  • Westfield Capital Management Company, LP

                  •  

                    1,464,259

                  • +3.74%

                  • 3.05

                  • BlackRock Fund Advisors

                  •  

                    1,330,601

                  • +4.48%

                  • 2.78

                  • State Street Corp

                  •  

                    1,247,573

                  • -1.19%

                  • 2.60

                  • MFS Investment Management K.K.

                  •  

                    1,218,287

                  • +28.02%

                  • 2.54

                  • Neuberger Berman LLC

                  •  

                    1,140,436

                  • +28.44%

                  • 2.38

                  • Frontier Capital Management CO Inc

                  •  

                    1,098,344

                  • -0.06%

                  • 2.29

                  • UBS Global Asset Mgmt Americas Inc

                  •  

                    1,033,894

                  • +60.80%

                  • 2.16

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Instruments & Supplies

                  Type

                  Aggressive Growth

                  Style

                  Mid Growth

                  Cooper Companies is a Delaware corporation organized in 1980. The Company is a medical device company. The Company operates through two business units: CooperVision, Inc. and CooperSurgical, Inc. They compete on the basis of product ...morequality and differentiation, technological benefit, service and reliability. CooperVision is engaged in the manufacture and sale of products for contact lens wearers. CooperVision develops, manufactures and markets monthly, two-week and single-use contact lenses, including advanced materials and optics. The contact lens market has two major product categories namely Spherical lenses including lenses that correct near- and farsightedness uncomplicated by more complex visual defects; and toric and multifocal lenses including lenses that address more complex visual defects ...moresuch as astigmatism and presbyopia by adding optical properties of cylinder and axis, which correct for irregularities in the shape of the cornea. CooperVision's in products are manufactured at its facilities located in Hampshire, United Kingdom, Juana Diaz, Puerto Rico, and West Henrietta, New York. It uses three different manufacturing processes to produce its lenses: lathing, cast molding and FIP(TM). CooperVision distributes products from West Henrietta, New York, Fareham, United Kingdom, Liege, Belgium, and other international distribution facilities. CooperSurgical focuses on supplying women's health clinicians with products and treatment options to improve the delivery of healthcare to women. CooperSurgical's offers products to aid clinicians in the management and treatment of commonly seen conditions. CooperSurgical customers are healthcare professionals and institutions providing care to and for women. CooperSurgical products support the point of healthcare delivery in the hospital, clinicians office and fertility clinics. CooperSurgical's manufacturing and distribution facilities are located in Trumbull, Connecticut, Malov, Denmark, Pasadena, California, Stafford, Texas, Golden, Colorado, and Berlin, Germany. The Company owns several manufacturing and research and development facilities, including 205,850 square feet in Hamble, United Kingdom, 49,500 square feet in Scottsville, New York, 63,787 square feet in Malov, Denmark, and 33,630 square feet in Stafford, Texas. The Company’s products and medical devices are subject to extensive regulation by the United States Food and Drug Administration in the United States and other regulatory bodies abroad. The Company also owns certain trade secrets, copyrights, know-how and other intellectual property.lessless

                  Key People

                  Mr. Robert S. Weiss

                  CEO/Director/President

                  Paul L. Remmell

                  President, Subsidiary/CEO, Subsidiary

                  Nicholas J. Pichotta

                  CEO, Subsidiary/President, Subsidiary

                  A. Thomas Bender

                  Chairman of the Board/Director

                  Dr. Allan E. Rubenstein,M.D.

                  Director/Vice Chairman of the Board

                  • Cooper Companies

                  • 6140 Stoneridge Mall Road

                  • Pleasanton, CA 94588

                  • USA.Map

                  • Phone: +1 925 460-3600

                  • Fax: -

                  • coopercos.com

                  Incorporated

                  1980

                  Employees

                  8,000

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: